Published in World J Urol on April 22, 2014
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus. Eur Urol (2011) 2.72
Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm. BJU Int (2008) 2.35
Surgical treatment of renal cancer with vena cava extension. Br J Urol (1987) 2.04
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int (2004) 2.00
Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol (2007) 1.96
Graft reconstruction of inferior vena cava for renal cell carcinoma stage pT3b or greater. Urology (2011) 1.80
Vena caval involvement by renal cell carcinoma. Surgical resection provides meaningful long-term survival. Ann Surg (1989) 1.71
Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience. J Urol (2008) 1.59
Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance. Cancer (2008) 1.58
Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi. Urology (2009) 1.47
Management of renal cell carcinoma with level III thrombus in the inferior vena cava. J Urol (2002) 1.29
Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol (2003) 1.25
Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol (2007) 1.15
Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi. Ann Surg (1990) 1.13
Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int (2005) 1.11
Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation. J Comput Assist Tomogr (2005) 1.07
Contemporary management of renal tumors with venous tumor thrombus. J Urol (2010) 1.04
Liver transplantation techniques for the surgical management of renal cell carcinoma with tumor thrombus in the inferior vena cava: step-by-step description. Eur Urol (2010) 1.04
The perioperative management of an inferior vena caval tumor thrombus in patients with renal cell carcinoma. Urol Oncol (2011) 1.04
Resection of renal tumors invading the vena cava. Urol Clin North Am (2008) 1.01
Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience. Eur Urol (2013) 1.01
Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful? World J Urol (2013) 0.98
Safety of intermittent Pringle maneuver cumulative time exceeding 120 minutes in liver resection: a further step in favor of the "radical but conservative" policy. Ann Surg (2012) 0.96
Neoadjuvant targeted therapy in a primary metastasized renal cell cancer patient leads to down-staging of inferior vena cava thrombus (IVC) enabling a cardiopulmonary bypass-free tumor nephrectomy: a case report. World J Urol (2012) 0.89
The accuracy of multidetector computerized tomography for evaluating tumor thrombus in patients with renal cell carcinoma. J Urol (2008) 0.85
Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system. Cancer (2007) 0.83
The role of transesophageal echocardiography in rapid diagnosis and treatment of migratory tumor embolus. Anesth Analg (2004) 0.82
Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy. J Urol (2007) 0.82
Robotic surgery and minimally invasive management of renal tumors with vena caval extension. Curr Opin Urol (2011) 0.79
Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int (2011) 0.79
A contemporary evaluation of cytoreductive nephrectomy with tumor thrombus: Morbidity and long-term survival. Urol Oncol (2004) 0.76
Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus. J Urol (2013) 0.76
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol (2013) 4.64
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer (2012) 2.95
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer (2013) 1.97
Chronic kidney disease and risk of renal cell carcinoma: differences by race. Epidemiology (2015) 1.78
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies. Int J Cancer (2013) 1.71
Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J Clin Oncol (2009) 1.55
Low Grade Micropapillary Urothelial Carcinoma, Does It Exist? - Analysis of Management and Outcomes from the Surveillance, Epidemiology and End Results (SEER) Database. J Cancer (2013) 1.54
CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis. J Urol (2009) 1.54
Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol (2012) 1.45
Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features. J Urol (2010) 1.43
Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies. Cancer (2008) 1.32
Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy. Cancer Epidemiol Biomarkers Prev (2009) 1.23
Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma. Cancer (2010) 1.18
Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma. Clin Cancer Res (2009) 1.16
Surveillance for renal cell carcinoma: why and how? When and how often? Urol Oncol (2007) 1.16
Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol (2007) 1.15
Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma. PLoS One (2013) 1.12
Multivariate analysis of the factors involved in loss of renal differential function after laparoscopic partial nephrectomy: a role for warm ischemia time. Can Urol Assoc J (2011) 1.08
Contemporary management of renal tumors with venous tumor thrombus. J Urol (2010) 1.04
Functional and oncological outcomes of partial nephrectomy of solitary kidneys. J Urol (2009) 0.96
Ultrasound-based combination therapy: potential in urologic cancer. Expert Rev Anticancer Ther (2011) 0.95
Serum levels of shed Her2/neu protein in men with prostate cancer correlate with disease progression. J Urol (2005) 0.94
The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma. J Urol (2011) 0.90
A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Carcinogenesis (2014) 0.88
Testicular Cancer, Version 2.2015. J Natl Compr Canc Netw (2015) 0.86
Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features. Am J Surg Pathol (2015) 0.81
Surgical management of large renal tumors. Expert Rev Anticancer Ther (2011) 0.80
A prospective study of leukocyte telomere length and risk of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev (2013) 0.80
MRI characterization of the dynamic effects of 5α-reductase inhibitors on prostate zonal volumes. Can J Urol (2013) 0.77
The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer. Can J Urol (2010) 0.76
Kidney cancer: Is incomplete renal ablation linked to tumour progression? Nat Rev Urol (2012) 0.75
The authors respond. Epidemiology (2015) 0.75
Editorial comment. J Urol (2011) 0.75
Adverse pathologic characteristics in the small renal mass: implications for active surveillance. Can J Urol (2017) 0.75
Immunological therapy in urological malignancy: novel combination strategies. Int J Urol (2010) 0.75
Prospective study comparing two techniques of renal clamping in laparoscopic partial nephrectomy: impact on perioperative parameters. J Endourol (2011) 0.75
Management of renal cell carcinoma in young patients and patients with hereditary syndromes. Curr Opin Urol (2016) 0.75
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2017) 0.75